Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares stood at 0.5 million during the latest session, with the company’s beta value hitting 0.70. At the
In last trading session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) saw 0.86 million shares changing hands with its beta currently measuring 0.70. Company’s recent per
Mereo Biopharma Group Plc ADR (NASDAQ:MREO) has a beta value of 0.80 and has seen 1.58 million shares traded in the last trading session. The
During the last session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares were 1.03 million, with the beta value of the company hitting 0.83. At
In the last trading session, 1.06 million shares of the Mereo Biopharma Group Plc ADR (NASDAQ:MREO) were traded, and its beta was 0.85. Most recently
In the last trading session, 1.25 million Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares changed hands as the company’s beta touched 0.82. With the company’s
In last trading session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) saw 1.65 million shares changing hands with its beta currently measuring 0.80. Company’s recent per
In the last trading session, 1.86 million shares of the Mereo Biopharma Group Plc ADR (NASDAQ:MREO) were traded, and its beta was 0.77. Most recently
Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares stood at 0.91 million during the latest session, with the company’s beta value hitting 0.77. At the
In last trading session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) saw 1.02 million shares changing hands with its beta currently measuring 0.78. Company’s recent per
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
